Achilles Therapeutics plc Quarterly Common Stock, Shares, Outstanding from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Achilles Therapeutics plc quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2020 to Q2 2024.
  • Achilles Therapeutics plc Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 41.1M shares, a 0.35% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 41.1M +142K +0.35% Jun 30, 2024 6-K 2024-08-14
Q4 2023 41.1M +150K +0.37% Dec 31, 2023 6-K 2024-08-14
Q2 2023 40.9M Jun 30, 2023 6-K 2023-08-04
Q4 2022 40.9M +329K +0.81% Dec 31, 2022 20-F 2024-04-04
Q4 2021 40.6M +36.2M +825% Dec 31, 2021 20-F 2023-03-07
Q4 2020 4.39M Dec 31, 2020 20-F 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.